000 01270 a2200373 4500
005 20250513150953.0
264 0 _c19980904
008 199809s 0 0 eng d
022 _a0031-6865
024 7 _a10.1016/s0031-6865(97)00043-5
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aBendas, G
245 0 0 _aSelectins as new targets for immunoliposome-mediated drug delivery. A potential way of anti-inflammatory therapy.
_h[electronic resource]
260 _bPharmaceutica acta Helvetiae
_cJun 1998
300 _a19-26 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650 0 4 _aAnimals
650 0 4 _aAnti-Inflammatory Agents
_xadministration & dosage
650 0 4 _aAntibodies
650 0 4 _aCHO Cells
_xmetabolism
650 0 4 _aCricetinae
650 0 4 _aDrug Delivery Systems
650 0 4 _aHumans
650 0 4 _aImmunoconjugates
_xmetabolism
650 0 4 _aLiposomes
650 0 4 _aMice
650 0 4 _aSelectins
_xmetabolism
700 1 _aKrause, A
700 1 _aSchmidt, R
700 1 _aVogel, J
700 1 _aRothe, U
773 0 _tPharmaceutica acta Helvetiae
_gvol. 73
_gno. 1
_gp. 19-26
856 4 0 _uhttps://doi.org/10.1016/s0031-6865(97)00043-5
_zAvailable from publisher's website
999 _c9673625
_d9673625